Advertisement

Topics

BRIEF-RaQualia Pharma gets sodium channel blocker patent allowance in China

19:01 EDT 22 Sep 2016 | Reuters

* Says it received an allowance for sodium channel blocker substance patent in China (Application No.201380022248.1)

Original Article: BRIEF-RaQualia Pharma gets sodium channel blocker patent allowance in China

NEXT ARTICLE

More From BioPortfolio on "BRIEF-RaQualia Pharma gets sodium channel blocker patent allowance in China"

Quick Search
Advertisement
 

Relevant Topic

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...